Negotiations are expected to continue in future cycles as part of President Donald Trump's "aggressive push for lower prices." ...

The negotiated prices are a result of a program passed by Congress in 2022 as part of the Inflation Reduction Act (IRA). The ...

The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.

The list of drugs seeing a price cut for Medicare recipients is increasing — some cancer meds are set to drop by thousands.

Medicare will save approximately 44%, on 15 high-cost medications as a result of the second round of the program’s drug price negotiations ...

ORLANDO — Education helped providers feel more comfortable using the General Anxiety Disorder-7 to screen children for ...

The price cuts will save Medicare billions of dollars in prescription-drug spending.

Novo Nordisk’s Ozempic, Astellas’ Xtandi and Pfizer’s Ibrance are among the 15 drugs that have a new fair maximum price.

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of the program’s price negotiations, touting a total of $12 billion ...

The Trump administration has announced new, lower Medicare prices for 15 drugs, including Ozempic, Wegovy, and key cancer treatments, effective in 2027.

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include Ozempic and also drugs to treat asthma, breast cancer and leukemia.